Roots Analysis has announced the addition of “Pharmaceutical Polymers / Medical Polymers Market, 2023 – 2035” report to its list of offerings.
Polymers have been employed in various fields, such as automotive, agriculture, construction, electronics, medical and textile. Specifically, in the pharmaceutical / medical sector, they find application as excipients in medicinal formulations, medical device components and packaging material, for dosage forms. Further, various stakeholders have developed innovative pharmaceutical / medical polymers, such as biodegradable polymers, stimuli-responsive polymers, shape memory polymers and self-healing polymers.
To order this 220+ page report, which features 65+ figures and 90+ tables, please visit this link
Around 40% of the industry stakeholders are based in Asia-Pacific, followed by those having headquarters in Europe (34%). In addition, majority of the companies produce amino-based pharmaceutical / medical polymers, followed by those manufacturing polysaccharide-based polymers. It is worth highlighting that 60% of the players manufacture synthetic pharmaceutical polymers / medical polymers.
Majority of the agreements related to pharmaceutical / medical polymers were observed to be focused on product development, representing nearly 30% of the total partnerships. Further, most of the intercontinental, as well as intracontinental deals have been inked by players based in Europe.
This framework takes into consideration the external forces (demographical) and internal forces (environmental, legal and technological) that may affect the strategic business of a company. In addition, it provides a consolidated view on the likely threats and opportunities within the pharmaceutical polymers / medical polymers domain.
The market in Asia-Pacific is likely to grow at a relatively faster pace (9.2%), in the long term. Currently, majority share (65%) of the overall pharmaceutical polymers / medical polymers market is captured by thermoplastic polymers; this trend is unlikely to change in the foreseen future as well. Further, by 2035, more than 45% of the market share is likely to be captured by pharmaceutical polymers / medical polymers intended for applications in medical devices.
To request a sample copy / brochure of this report, please visit this link
The financial opportunity within the pharmaceutical polymers / medical polymers market has been analyzed across the following segments:
The report also features inputs from eminent industry stakeholders, according to whom, the continuously rising demand for novel polymeric medical devices, coupled to the ongoing technological advancements in this domain is likely to drive the growth of the overall pharmaceutical polymers / medical polymers market, in the foreseen future. The report includes detailed transcripts of discussions held with the following experts:
The research includes profiles of key players (listed below) engaged in this domain; each profile features a brief overview of the company, details related to its financial performance (if available), pharmaceutical polymers / medical polymers focused portfolio, recent developments and an informed future outlook.
For additional details, please visit https://www.rootsanalysis.com/reports/medical-polymers-market.html or email sales@rootsanalysis.com
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
MEDIA CITATIONS
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES
.png)
